These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3930609)

  • 1. A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells.
    Tan LK; Oi VT; Morrison SL
    J Immunol; 1985 Nov; 135(5):3564-7. PubMed ID: 3930609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of mouse V/human C chimeric kappa genes by homologous recombination in hybridoma cells. Analysis of vector design and recombinant gene expression.
    Sun W; Xiong J; Shulman MJ
    J Immunol; 1994 Jan; 152(2):695-704. PubMed ID: 8283045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
    Wang LL; Han H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the effect of a strain-specific alteration in the upstream octamer region on transcription of a mouse V kappa Ser light chain gene.
    Goldrick MM; Gottlieb PD
    J Immunol; 1988 Jan; 140(2):646-53. PubMed ID: 2447185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a recombinant murine IgE in transfected myeloma cells.
    Gritzmacher CA; Liu FT
    J Immunol; 1987 Jan; 138(1):324-9. PubMed ID: 2431059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic markers of variable region of mouse myeloma MOPC 21 light chain].
    Vengerova TI; Petrosian MN; Bogacheva GT; Rokhlin OV
    Mol Biol (Mosk); 1979; 13(6):1303-11. PubMed ID: 94936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin K chain genes in mouse hybridoma PTF-02 and parent myeloma. Insertion of hybridoma K gene into the plasmid pSV2-gpt.
    Stepchenko AG; Deyev SM; Polyanovsky OL; Kovár J; Franĕk F
    Folia Biol (Praha); 1986; 32(3):161-6. PubMed ID: 3017773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of "chimeric" (murine/human) immunoglobulin genes in lymphoid and nonlymphoid cells].
    Deev SM; Liber A; Rad'ko BV; Polianovskiĭ OL
    Mol Biol (Mosk); 1994; 28(2):429-36. PubMed ID: 8183275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells.
    Hozumi N; Wu G; Murialdo H; Baumal R; Mosmann T; Winberry L; Marks A
    J Immunol; 1982 Jul; 129(1):260-6. PubMed ID: 6806362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational events in mouse myeloma cells.
    Morrison SL; Scharff MD
    Crit Rev Immunol; 1981 Sep; 3(1):1-22. PubMed ID: 6807601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
    Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes.
    Cory S; Tyler BM; Adams JM
    J Mol Appl Genet; 1981; 1(2):103-16. PubMed ID: 6286818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
    Morrison SL; Johnson MJ; Herzenberg LA; Oi VT
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6851-5. PubMed ID: 6436822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
    Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
    Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric contribution to Ig repertoire diversity by V kappa exons: differences in the utilization of V kappa 10 exons.
    Fitzsimmons SP; Rotz BT; Shapiro MA
    J Immunol; 1998 Sep; 161(5):2290-300. PubMed ID: 9725223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.